Temperature Management in Comatose Post-MI Patients

Primary Temperature Management Strategy

The American Heart Association recommends actively preventing fever by targeting a temperature ≤37.5°C for at least 36-72 hours in comatose patients after myocardial infarction complicated by cardiac arrest, selecting a constant target temperature between 32°C and 36°C if using targeted temperature management 1
The International Consensus guidelines recommend against routine hypothermia versus normothermia, as no survival or neurological benefit has been demonstrated between these approaches, with a critical distinction that all comatose post-cardiac arrest patients require active temperature control 1, 2

Target temperature range: 32°C to 36°C when using active temperature management devices with feedback systems, as recommended by the American Heart Association 1, 2
Maintain constant temperature for at least 24 hours after achieving target, with a recommendation to continue fever prevention (≤37.5°C) for 36-72 hours in patients who remain comatose 1, 3

The European Society of Cardiology recommends that primary PCI should not be delayed by temperature management and can be performed simultaneously with cooling initiation, with emergency coronary angiography being a Class I recommendation regardless of temperature management status 5
Hypothermia conditions slow antiplatelet drug absorption and reduce clopidogrel hepatic conversion, with cooling able to be started in the catheterization laboratory during PCI 5

Targeted temperature management at 33°C causes decreased heart rate, elevated lactate, and increased vasopressor requirements compared to 36°C, which may influence target temperature selection toward the higher end of the range (36°C) in post-MI patients with potential cardiogenic shock 4

The American Heart Association recommends using temperature control devices with feedback systems based on continuous core temperature monitoring, with surface cooling and endovascular cooling showing equivalent outcomes 1
Core temperature monitoring via esophageal, bladder, or pulmonary artery catheters is essential, with axillary and oral measurements being inadequate 6, 7

The American Heart Association strongly recommends against using prehospital rapid infusion of large volumes of cold IV fluid, with a moderate-certainty evidence 1, 2, 5
Select target temperature (32-36°C range) based on hemodynamic stability and institutional protocol, with achievement of target temperature and maintenance for 24 hours being recommended 1, 3

Allowing uncontrolled fever is associated with worse neurological outcomes, with active prevention being mandatory 1, 2
Premature rewarming may theoretically increase complications, with a recommended rewarming rate of approximately 0.25°C/hour 1, 7
Inadequate anticoagulation monitoring is a common error, with hypothermia impairing coagulation and control of active bleeding being necessary before cooling 7
Ignoring ECG changes, such as J-point elevation (Osborn waves), QT prolongation, and ST-segment changes, is a critical pitfall to avoid 8

Hypokalemia, thrombocytopenia, and increased infection risk occur with deeper hypothermia, with arrhythmias and bradycardia being common complications 6, 7, 8
Hyperglycemia requires management during cooling, with close monitoring being essential 7